Liraglutide and exenatide are potent medications classified belonging to GLP-1 receptor agonists. These drugs mimic the effects of naturally generated glucagon-like peptide-1 (GLP-1), a hormone crucial for regulating blood glucose levels. Both liraglutide and exenatide demonstrate efficacy in managing type 2 diabetes by prompting pancreatic beta ce